Barricaid maker Intrinsic Therapeutics among top 20 private medtech companies

The Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular Closure is accessible to patients and surgeons.

Intrinsic Therapeutics’ Barricaid device is the only FDA PMA-approved annular closure implant. Studies have shown that annular closure may be a good option for certain patients. Barricaid is backed by substantial clinical evidence, including a Level 1 randomized, controlled trial.

Interested in learning more? Please visit our company page.

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.